Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Allergen immunotherapy (9)
  • x Asthma (4)
  • Basic immunology (3)
  • Biologicals (2)
  • ENT (2)
  • Eosinophilic esophagitis (1)
  • Epidemiology (1)
  • Food allergy (11)
  • Ocular allergy (1)
  • Pediatrics (1)
Poster available until
Poster categories
  • Thematic Poster Session (4)
keywords
Session Reference
  • L-TPS02 (14)
  • L-TPS09 (6)
  • L-TPS10 (12)
  • L-TPS16 (14)
  • L-TPS18 (2)
  • L-TPS19 (1)
  • TPS06 (9)
  • TPS07 (11)
  • TPS08 (1)
  • x TPS09 (4)
  • TPS19 (1)
  • TPS25 (1)
  • TPS28 (1)
  • TPS29 (15)
  • TPS30 (11)
  • TPS31 (15)
  • TPS51 (9)
  • TPS55 (13)
  • TPS56 (16)
  • TPS57 (12)
  • TPS69 (1)
4 results
Thumbnail

D1.149 - Murine IgG1 increased y subcutaneous immunotherapy suppressed development of allergic asthma

Thumbnail

D1.150 - Study design for the saFety assessment of an Accelerated up-dosing scheme using one Strength of a native house dust mite allergen extract for subcutaneous immunoTherapy in children with allergic asthma in China (FAST II study)

Thumbnail

D1.153 - Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites

Thumbnail

D1.154 - Safety of ultra-rush immunotherapy starting protocol with the molecular extract Diater Alt a 1 mol mix

Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM